We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MTNB market cap is 44.97M. The company's latest EPS is USD -0.0915 and P/E is -1.97.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.1M | 0 | 0 | 0 | 0 |
| Operating Income | -5.59M | -6.16M | -6.13M | -5.89M | -5.9M |
| Net Income | -5.51M | -6.06M | -6.06M | -5.31M | -5.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 90k | 158k | 33k | 3.19M | 1.1M |
| Operating Income | -18.92M | -24.21M | -24.74M | -24.59M | -23.77M |
| Net Income | -18.3M | -23.24M | -23.68M | -21M | -22.94M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 38.26M | 34.03M | 29.79M | 25.1M | 19.61M |
| Total Liabilities | 5.64M | 6.17M | 6.64M | 5.86M | 5.05M |
| Total Equity | 32.63M | 27.85M | 23.15M | 19.25M | 14.56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 40.24M | 70.97M | 61.33M | 44.82M | 25.1M |
| Total Liabilities | 7.19M | 7.24M | 8.83M | 8.18M | 5.86M |
| Total Equity | 33.05M | 63.73M | 52.49M | 36.64M | 19.25M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.09M | -6.28M | -10.7M | -15.28M | -5.77M |
| Investing | 3M | 9.2M | 10.28M | 13.24M | 2M |
| Financing | -4k | -5k | -6k | -7k | 53k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.09M | -17.37M | -15.22M | -19.16M | -15.28M |
| Investing | -6.01M | -40.67M | 16.77M | 4.88M | 13.24M |
| Financing | 29.85M | 48.05M | 6.97M | 79k | -7k |
| Market Cap | 44.97M |
| Price to Earnings Ratio | -1.97 |
| Price to Sales Ratio | 40.91 |
| Price to Cash Ratio | 9.42 |
| Price to Book Ratio | 2.35 |
| Dividend Yield | - |
| Shares Outstanding | 250.82M |
| Average Volume (1 week) | 1.24M |
| Average Volume (1 Month) | 890.28k |
| 52 Week Change | -50.19% |
| 52 Week High | 0.89 |
| 52 Week Low | 0.1103 |
| Spread (Intraday) | 0 (1.72%) |
| Company Name | Matinas Biopharma Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.matinasbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
